QT
FATE icon

Quantamental Technologies’s Fate Therapeutics FATE Stock Holding History

Quantamental Technologies’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,526
Closed -$211K – 552
2022
Q2 		$211K Buy
+8,526
New +$235K 0.1% 343
2022
Q1 		– Sell
-5,873
Closed -$344K – 433
2021
Q4 		$344K Buy
+5,873
New +$333K 0.17% 221
2020
Q4 		– Sell
-6,336
Closed -$253K – 157
2020
Q3 		$253K Buy
+6,336
New +$221K 0.19% 187
2019
Q4 		– Sell
-5,982
Closed -$93K – 718
2019
Q3 		$93K Buy
+5,982
New +$115K 0.03% 766
2019
Q2 		– Sell
-78
Closed -$1K – 1576
2019
Q1 		$1K Buy
+78
New +$1.23K ﹤0.01% 1410

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Quantamental Technologies's FATE Position: Q3 2022 in Review

Quantamental Technologies sold out of Fate Therapeutics (FATE) in Q3 2022, closing a stake of 8,526 shares — an estimated $211K sold.

Quantamental Technologies first reported a position in FATE in Q1 2019 and held it in 5 quarters. The position peaked at $344K in Q4 2021. 239 funds tracked by Wall St. Rank hold FATE as of Q3 2022.

  • Quantamental Technologies reported no remaining Fate Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Quantamental Technologies sold 8,526 Fate Therapeutics shares in Q3 2022, an estimated $211K.
  • Quantamental Technologies first reported a position in Fate Therapeutics in Q1 2019 and held it in 5 quarters.
  • Quantamental Technologies's Fate Therapeutics position peaked at $344K in Q4 2021.
  • 239 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2022.

Based on Quantamental Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.